Meeting
2012 ASCO Annual Meeting
Multicenter retrospective analysis of systemic chemotherapy for advanced poorly differentiated neuroendocrine carcinoma of the digestive system.
Authors
Nozomu Machida
Shizuoka Cancer Center, Shizuoka, Japan
Nozomu Machida , Tomohiro Yamaguchi , Akiyoshi Kasuga , Hideaki Takahashi , Kentaro Sudo , Tomohiro Nishina , Kazutoshi Tobimatsu , Kenji Ishido , Junji Furuse , Narikazu Boku
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 30, 2012 (suppl; abstr 4046)
DOI
10.1200/jco.2012.30.15_suppl.4046
Abstract #
4046
Poster Bd #
41E
Abstract Disclosures
Similar Posters
Poster
2012 Gastrointestinal Cancers Symposium
Multicenter retrospective analysis of systemic chemotherapy in poorly differentiated neuroendocrine carcinoma of the digestive system.
First Author: Tomohiro Yamaguchi
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Randomized phase III study of etoposide plus cisplatin versus irinotecan plus cisplatin in advanced neuroendocrine carcinoma of the digestive system: A Japan Clinical Oncology Group study (JCOG1213).
First Author: Chigusa Morizane
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic factors for overall survival in patients with advanced digestive neuroendocrine carcinoma treated with first-line cisplatin-based chemotherapy: A post-hoc analysis of JCOG1213.
First Author: Hidekazu Hirano
Poster
2022 ASCO Annual Meeting
Randomized phase II study of platinum and etoposide (EP) versus temozolomide and capecitabine (CAPTEM) in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): ECOG-ACRIN EA2142.
First Author: Jennifer Rachel Eads